Investment objective & strategy
As of Aug. 27, 2024 · prospectusObjective. The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the NYLI Candriam Healthy Hearts Index (the Underlying Index).
Strategy. The Fund employs a passive management or indexing investment approach designed to track the performance of the Underlying Index. The Advisor is the index provider for the Underlying Index and Candriam serves as the index consultant to the Advisor for the Underlying Index. The Underlying Index incorporates thematic selection criteria designed to provide exposure to equity securities of companies that are making a positive contribution to global health-related goals, such as by providing solutions for monitoring and curing heart diseases or helping people adopt a healthy lifestyle that limits cardiovascular risks. As of June 30, 2024, the primary sectors within the Underlying Index were h ealth care, consumer discretionary, and information technology. The Underlying Index includes securities of large-, mid- … The Fund employs a passive management or indexing investment approach designed to track the performance of the Underlying Index. The Advisor is the index provider for the Underlying Index and Candriam serves as the index consultant to the Advisor for the Underlying Index. The Underlying Index incorporates thematic selection criteria designed to provide exposure to equity securities of companies that are making a positive contribution to global health-related goals, such as by providing solutions for monitoring and curing heart diseases or helping people adopt a healthy lifestyle that limits cardiovascular risks. As of June 30, 2024, the primary sectors within the Underlying Index were h ealth care, consumer discretionary, and information technology. The Underlying Index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates. As of June 30, 2024, the market capitalization range of the Underlying Index was approximately $1.10 billion to $3.23 trillion. The initial universe for the Underlying Index consists of the constituents of a third-party index designed to track the performance of the investable universe covering approximately the largest 99% of the free-float market capitalization in the global markets. The Underlying Index includes thematic selection criteria that reflect initiatives, research and programs of the American Heart Association, Inc., a 501(c)(3) public charity, (American Heart Association). Each of the thematic screens addresses issues or areas historically supported by the American Heart Association. The American Heart Association is the nations oldest and largest voluntary organization dedicated to fighting heart disease and stroke. The thematic selection criteria used by the Underlying Index to identify and score companies for potential inclusion in the Index are: Diagnosis and/or treatment of cardiovascular diseases, such as atherosclerosis, thrombosis, heart attack and vascular surgery; Manufacturing and distribution of healthy food; Manufacturing and distribution of wellness products; Providing services allowing people to access information about health and thereby make better informed decisions; and Providing solutions for people to track their fitness and engage in healthy lifestyle. Each eligible company is assigned a score between 0-10 for determining which constituents are to be included in the Underlying Index. This scoring is based upon either: (i) the percentage or dollar value of revenue that the company derives from activities relevant to the theme; or (ii) a measure of the impact a companys activity has on the theme. The security selection process also includes an exclusionary screen based on any continued and significant non-compliance with the principles within the United Nations Global Compact as well as the exclusion of companies engaged in certain businesses beyond minimum thresholds (e.g., companies that operate in countries with oppressive regimes, that operate in adult content, alcohol, vaping, armament, gambling, nuclear, and tobacco and non-research, non-prescription or recreational cannabis sectors, or that utilize animal testing or genetic modification in research and development). Following the application of the exclusionary screens, the Underlying Index selects the top-ranked 50 to 80 companies for inclusion based on the thematic selection criteria scoring. The number of companies selected for inclusion in the Underlying Index will vary depending on the number of companies that exceed the thematic screening score required for inclusion in the Underlying Index. Securities selected for inclusion in the Underlying Index are weighted using a modified market capitalization-weighting methodology, with a minimum component weight of 0.5% and maximum component weight of 5% at the time of rebalance. The Underlying Index is rebalanced quarterly. The Underlying Index applies the exclusionary screen on a monthly basis and any company identified in the exclusionary screen is removed from the Underlying Index. The Underlying Index may include as a component one or more ETFs advised by the Advisor (Affiliated ETFs) and the Fund will typically invest in any Affiliated ETF included in the Underlying Index. The Fund also may invest in Affiliated ETFs that are not components of the index if such an investment will help the Fund track the Underlying Index.
Top holdings
As of July 31, 2025 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| ALPHABET INC CL A | — | $497.79K | 5.74% |
| JOHNSON&JOHNSON | — | $472.97K | 5.46% |
| ASTRAZENECA PLC | — | $461.86K | 5.33% |
| APPLE INC | — | $460.39K | 5.31% |
| Novartis AG (Registered) | NVSEF | $451.55K | 5.21% |
| LILLY ELI and CO | — | $447.00K | 5.16% |
| BOSTON SCIENTIFIC CORP | — | $444.13K | 5.12% |
| PFIZER INC | — | $441.76K | 5.10% |
| ABBOTT LABS | — | $420.97K | 4.86% |
| UNITEDHEALTH GRP | — | $368.35K | 4.25% |
Portfolio moves
Apr 30, 2025 → Jul 31, 2025How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| JPMorgan Healthcare Leaders ETF · JDOC | 35% | 0.65% |
| Schwab Health Care Fund · SWHFX | 33% | 0.80% |
| Portfolio Building Block World Pharma and Biotech Index ETF | 33% | — |
Advisers
| Firm | Role |
|---|---|
| New York Life Investment Management LLC | Adviser |
Footnotes
- Expense ratio as of August 27, 2024, from the fund's prospectus.
- Net assets and holdings count as of July 31, 2025, from the fund's N-PORT filing.
- Total return for calendar year 2024, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2024 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.